vetting a facility before you trust it
Confirm medical credentials, continuous monitoring capability, and emergency readiness from intake through discharge — in writing, not just verbally on a call.
Insist on a full medication review to map drug interactions and QT risk, including overlap with methadone or antibiotics you may already be taking.
A legitimate facility will welcome direct, specific questions and provide clear written policies on hydration, labs, and emergency protocol without pushback. Reluctance to answer specifics is itself a signal.
For location research, one starting point is this directory of ibogaine treatment facilities — treat any directory listing as a starting point for your own verification, not a substitute for it.
Many programs operate in Mexico, where oversight varies by facility; a curated directory of ibogaine centers in Mexico can help narrow the search, but the vetting checklist below still has to be applied to each option individually.
A directory listing gets you to roughly this point. Direct verification of the items in the checklist is the rest of the work.
how the options actually compare
Small samples report reduced withdrawal and cravings. Requires travel, carries real legal and anti-doping exposure, and depends entirely on the quality of a specific clinic's cardiac monitoring.
Buprenorphine and methadone have the strongest evidence base for survival and treatment retention. Domestic access is typically simpler, and there's no anti-doping conflict to navigate.
Unmonitored or under-screened use is where the documented deaths cluster. This isn't a hypothetical caution — it's the pattern in the case reports.
Ibogaine is metabolized to noribogaine via CYP2D6, extending the window of mood and craving effects well past the acute experience.
Targets include the NMDA receptor, kappa opioid receptor, and serotonin systems, with increased BDNF and GDNF observed in animal studies — not yet confirmed in humans.
Blocking the cardiac hERG channel produces QT prolongation, raising arrhythmia risk, including documented cases of torsades de pointes and death.
Rigorous labs, corrected electrolytes, and real-time cardiac monitoring reduce — but do not eliminate — that risk.
A responsible workflow starts with screening and risk counseling under direct medical supervision, not with booking a session.
Aftercare follows with a structured cadence before any return to full training.